Navigation Links
Spectrum Announces bioWorld Distribution Agreement
Date:2/6/2013

New Brunswick, NJ (PRWEB) February 06, 2013

Spectrum Chemicals & Laboratory Products has become a premier distributor for bioWorld, an internationally recognized manufacturer of bioaffinity matrices and reagents for proteomics research. This agreement provides Spectrum access to one of the most comprehensive line of life sciences and biotechnology products for research, including affinity chromatography, molecular biology, cell culture and microbiological reagents.

Spectrum’s major emphasis is on active pharmaceutical ingredients and controlled substances, excipients, dietary supplements, cosmetic ingredients, biochemicals, and a complete line of high-purity solvents for critical analytical applications. "The addition of bioWorld’s Separopore® bioAffinity Matrices for Protein Purification and related buffers and reagents for proteomics expands Spectrum’s current footprint in analytical applications, with a wide range of protein purification reagents not available in the market place. bioWorld’s line of research reagents gives Spectrum access to one of the most comprehensive lines of life sciences and biotechnology products for research, including affinity chromatography, molecular biology, cell culture and microbiology", says Mark Hurd, Spectrum’s General Manager. He adds, "We are committed to increasing our profile across all aspects of life science research from buffers and reagents to high-quality, easy-to-use research kits."

About Spectrum Chemicals & Laboratory Products
Founded in 1971, Spectrum Chemicals & Laboratory Products manufactures and distributes fine chemicals for production and laboratory facilities around the globe. All of Spectrum's worldwide facilities are ISO 900
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Cempra Inc. Presents Additional Data on the Clinical Profile and Activity Spectrum of Solithromycin at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
2. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
3. Life Technologies Announces Fourth Quarter and Fiscal 2012 Results
4. United Therapeutics Announces Additional $420 Million Share Repurchase Program
5. Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40
6. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
7. Governor Cuomo Announces Continued Growth at Roswell Park Cancer Institute with Regional Economic Development Council Funding; RPCI Center for Personalized Medicine established with CTG (NASDAQ: CTGX) serving as its technology partner
8. Undiscovered Companies Announces A Video Interview Of Hidden Bio-Tech Company Immunotech Laboratories
9. Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast
10. ComplianceOnline Announces Seminar on Statistical Analysis for Product Development
11. Navigating Cancer Announces Jeff Oberlander as VP, Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , September 2, 2015 ... primär auf die Forschung und Entwicklung neuartiger ... Allergien, chronisch-entzündliche Darmerkrankungen und Reizdarm konzentriert, erhält ... Zusage, dass sein neues Medikament patentiert wird. ... das Allergien bei Kindern verhindert und Entzündungen ...
(Date:9/1/2015)... N.J. , Sept. 1, 2015  ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... & Renshaw 17 th Annual Global Investment Conference ... place September 8-10, 2015 at The St. Regis Hotel ... James Sapirstein , Chief Executive Officer, ...
(Date:9/1/2015)... Eau Claire, WI (PRWEB) , ... September 01, 2015 , ... ... 2015), Alexi Venice expertly transports the reader to a not-so-distant future faced with an ... McCallan, a beautiful professional who overcomes personal tragedy to enter the world of counterterrorism, ...
(Date:9/1/2015)... 2015 The Dohmen Company today announced ... MBA as Chief Science Officer (CSO) of Dohmen ... role, Dr. Floyd will lead Dohmen,s growing regulatory ... pre-commercial and post approval outsourced services in quality, ... Dr. Floyd brings decades of experience leading global ...
Breaking Biology Technology:Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3
... YORK, Feb. 17 The following is from Betsy ... "Ruin Your Health With the Obama Stimulus Plan."I am ... a correction. Mr. Olbermann charges that I, Betsy McCaughey, ... industry, the biotech industry, the Hudson Institute, or Cantel ...
... Mass., Feb. 17 Idenix Pharmaceuticals, Inc. (Nasdaq: ... development of drugs for the treatment of human viral and ... fourth quarter and year ended December 31, 2008. At December ... $46.1 million. Business Highlights , , ...
... ... DE (Vocus) February 17, 2009 -- DuPont today announced that ... are in compliance with the Excellence Through StewardshipSM (ETS) ... confirms that the company uses the tools of biotechnology ethically and ...
Cached Biology Technology:Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 7DuPont Biotech Stewardship Program Gains External Certification 2DuPont Biotech Stewardship Program Gains External Certification 3
(Date:8/5/2015)... New York , August 5, 2015 ... market report titled "Facial Recognition Market - Global Industry ... 2022", the global market for facial recognition is forecast ... is driven by increased demand for surveillance systems by ... the rising number of crimes and terrorist activities across ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:8/3/2015)... Synaptics, Inc. (Nasdaq: SYNA ), the ... members of the executive management team will present to ... Leadership Forum on Tuesday, August 11, 2015 at 1:00 ... the Sonnenalp Resort in Vail, CO. ... information. An audio webcast of the event will be ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... In unprecedented new research, scientists at Rice University ... time to both predict theoretically and verify experimentally ... , The interdisciplinary research appears this week in ... National Academy of Sciences. , "Researchers have successfully ...
... computerized system to easilymonitor the levels of glucose in ... published today in the open access journal BMC MedicalInformatics ... assists in the monitoring of glucose levels incritically ill ... than the paper-based method currently used in manyintensive care ...
... protein called vasostatin may prove a promising new way of ... Gut. , Pancreatic cancer is the fifth leading cause of ... to treat. Only 3% of affected patients are still alive ... static for the past three decades. , Currently, the only ...
Cached Biology News:Free-energy theory borne out in large-scale protein folding 2Free-energy theory borne out in large-scale protein folding 3Jefferson researchers find nanoparticle shows promise in reducing radiation side effects 2
Polyclonal Antibody to SHPRH...
Rabbit polyclonal to TetR ( Abpromise for all tested applications). Antigen: Synthetic peptide: AQKLGVEQPTLYWHVKNKR, corresponding to amino acids 31 - 49 of TetR...
Biotin anti-mouse Ly-49C/F/I/H...
Peptide-affinity Purified Polyclonal Antibody to Retinoic Acid-Induced 3 (RAI3/RAIG1)...
Biology Products: